J
Jennifer L. Alejo
Researcher at Johns Hopkins University
Publications - 60
Citations - 795
Jennifer L. Alejo is an academic researcher from Johns Hopkins University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 7, co-authored 18 publications receiving 273 citations. Previous affiliations of Jennifer L. Alejo include Johns Hopkins University School of Medicine & University of Virginia.
Papers
More filters
Journal ArticleDOI
Survival Benefit of Primary Deceased Donor Transplantation With High-KDPI Kidneys
Allan B. Massie,Xun Luo,Eric K.H. Chow,Jennifer L. Alejo,Niraj M. Desai,Dorry L. Segev,Dorry L. Segev +6 more
TL;DR: Benefit of high‐KDPI KT was greatest in patients age >50 years and patients at centers with median wait time ≥33 months, and in patientsAge >50 Years and patients with median waiting time ≥34 months.
Journal ArticleDOI
Antibody Response to a Fourth Dose of a SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series.
Jennifer L. Alejo,Jonathan Mitchell,Teresa P.-Y. Chiang,Aura T. Abedon,Brian J. Boyarsky,Robin K. Avery,Aaron A.R. Tobian,Macey L. Levan,Allan B. Massie,Jacqueline Garonzik-Wang,Dorry L. Segev,William A. Werbel +11 more
TL;DR: This research presents a novel probabilistic approach that allows us to assess the importance of knowing the carrier and removal status of canine coronavirus as a source of infection for other animals.
Journal ArticleDOI
Temporary hold of mycophenolate augments humoral response to SARS-CoV-2 vaccination in patients with rheumatic and musculoskeletal diseases: a case series.
Caoilfhionn M Connolly,Teresa Po-Yu Chiang,Brian J. Boyarsky,Jake A Ruddy,Mayan Teles,Jennifer L. Alejo,Allan B. Massie,William A. Werbel,Ami A. Shah,Lisa Christopher-Stine,Jacqueline Garonzik-Wang,Dorry L. Segev,Julie J. Paik +12 more
TL;DR: In this article, the impact of withholding perivaccination mycophenolate in 24 patients with rheumatic and musculoskeletal diseases (RMD) was analyzed using an observational prospective cohort of patients who underwent SARS-CoV-2 vaccination between 17 December 2020 and 13 May 2021.
Posted ContentDOI
A Third Dose of SARS-CoV-2 Vaccine Increases Neutralizing Antibodies Against Variants of Concern in Solid Organ Transplant Recipients
Andrew H. Karaba,Xianming Zhu,Tao Liang,Kristy H Wang,Alex G Rittenhouse,Olivia Akinde,Yolanda Eby,Joel N. Blankson,Aura T. Teles,Jennifer L. Alejo,Andrea L. Cox,Andrea L. Cox,Justin R. Bailey,Sabra L. Klein,Sabra L. Klein,Andrew Pekosz,Andrew Pekosz,Jacqueline Garonzik-Wang,Brian J. Boyarsky,Dorry L. Segev,Aaron A.R. Tobian,William A. Werbel +21 more
TL;DR: For example, this article showed that a third SARS-CoV-2 vaccine dose increased median anti-spike (1.6-fold) and receptor-binding domain(1.5fold) IgG, as well as pseudoneutralization against VOCs (2.5-fold versus Delta).
Journal ArticleDOI
Prevalence and Durability of SARS-CoV-2 Antibodies Among Unvaccinated US Adults by History of COVID-19.
Jennifer L. Alejo,Jonathan Mitchell,Amy Chang,Teresa Po-Yu Chiang,Allan B. Massie,Dorry L. Segev,Martin A. Makary +6 more
TL;DR: This work characterized natural immunity and long-term durability among unvaccinated individuals using anti–spike antibodies, the first line of defense against SARS-CoV-2.